Assyro AI

Orange Book product · Brand (NDA)

SODIUM IODIDE I 123

SODIUM IODIDE I-123

Brand (NDA)NDA 018671TE AARX CARDINAL HEALTH 418

At a glance

May 27, 1982

Approved

Brand (NDA)

Application

AA

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 27, 1982

    44 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SODIUM IODIDE I-123

Strength

200uCi

Dosage form

CAPSULE

Route

ORAL

TE code

AA

Application

NDA 018671

Product number

002

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.